The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - UroGen pharma
The uTRACT registry: A single-arm, multicenter, prospective, and retrospective registry study to evaluate the real-world use of UGN-101 in participants with upper tract urothelial carcinoma (UTUC) in the United States.
 
Adam Feldman
Honoraria - UroGen pharma
Research Funding - UroGen pharma (Inst)
 
Yair Lotan
Stock and Other Ownership Interests - CAPs medical; Nanorobotics; Phinomics; trigone pharma; Uroviu; vesica health; Vessi Medical; Virtuoso Therapeutics
Consulting or Advisory Role - Abbvie; Ambu; AstraZeneca; Aura Biosciences; Bristol-Myers Squibb; caps medical; Cleveland Diagnostics; Convergent Genomics; Fergene; ImmunityBio; Janssen; Merck; Nanogen Biopharmaceutical; Nanorobotics; nrx pharmaceuticals; Nucleix; pacific edge; phinomics; Photocure; Seagen; Stimit; trigone pharma; Urogen pharma; uroviu; verity pharmaceuticals; Vessi Medical; virtuoso surgical; Xcures
Research Funding - Abbott Molecular (Inst); Augmenix; BioCancell (Inst); Cepheid; Cepheid (Inst); GenomeDx (Inst); MDxHealth (Inst); pacific edge; pacific edge (Inst); Photocure (Inst); storz (Inst)
 
Soloman Woldu
Research Funding - UroGen pharma (Inst)
 
Mehrad Adibi
Research Funding - UroGen pharma (Inst)
 
Marc Bjurlin
Consulting or Advisory Role - UroGen pharma
Research Funding - UroGen pharma
 
Eliza DeFroda
Employment - Stryker (I)
Research Funding - UroGen pharma
 
Rian Dickstein
Employment - Chesapeake Urology
Honoraria - UroGPO
Consulting or Advisory Role - CG Oncology; Ferring; Johnson & Johnson/Janssen; Olympus; Photocure; Urogen pharma
Speakers' Bureau - Ferring; Urogen pharma
 
Khurshid Ghani
Honoraria - Boston Scientific; Olympus Medical Systems
Consulting or Advisory Role - Boston Scientific; Coloplast; Karl Storz; Olympus; UroGen pharma
Research Funding - Boston Scientific; Coloplast; UroGen pharma
Patents, Royalties, Other Intellectual Property - University of Michigan
Travel, Accommodations, Expenses - Boston Scientific; Olympus Medical Systems
 
David Hoenig
Research Funding - UroGen pharma
 
Joseph Jacob
Consulting or Advisory Role - Aura Biosciences; Janssen; Pfizer
 
Hristos Kaimakliotis
Consulting or Advisory Role - Early is good
Research Funding - UroGen pharma
 
Jennifer Linehan
Consulting or Advisory Role - Medtronic
Speakers' Bureau - Intuitive Surgical; UroGen pharma
Research Funding - UroGen pharma
Travel, Accommodations, Expenses - Intuitive Surgical; Medtronic; UroGen pharma
 
Joshua Meeks
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; CG Oncology; ferring; ImmunityBio; Imvax; Janssen; Merck; Pfizer; Photocure; Prokarium; Protara Therapeutics; Urogen pharma
Patents, Royalties, Other Intellectual Property - NMIBC genetic classifier (Inst); TCGA Classifier (Inst)
Other Relationship - Olympus
 
Katie Murray
Consulting or Advisory Role - Urogen pharma
Speakers' Bureau - Urogen pharma
 
Nirmish Singla
No Relationships to Disclose
 
Karthik Tanneru
Research Funding - UroGen pharma
 
Hetal Pandya
Employment - UroGen pharma
Stock and Other Ownership Interests - UroGen pharma
 
Nikky Ugwuoke
Employment - UroGen pharma
Stock and Other Ownership Interests - UroGen pharma
 
Brent Burger
Employment - UroGen pharma
Stock and Other Ownership Interests - UroGen pharma
 
Michael Louie
Employment - UroGen pharma
Stock and Other Ownership Interests - UroGen pharma
 
uTRACT Registry Study Group
No Relationships to Disclose